AP2238 was the first compound published to bind both anionic sites of the human acetylcholinesterase, allowing the simultaneous inhibition of the catalytic and the amyloid-beta pro-aggregating activities of AChE. Here we attempted to derive a comprehensive structure-activity relationship picture for this molecule, affording 28 derivatives for which AChE and BChE inhibitory activities were evaluated. Selected compounds were also tested for their ability to prevent the AChE-induced Abeta-aggregation. Moreover, docking simulations and molecular orbital calculations were performed.
Titolo: | Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives. |
Autore/i: | PIAZZI, LORNA; CAVALLI, ANDREA; BELLUTI, FEDERICA; BISI, ALESSANDRA; GOBBI, SILVIA; Rizzo S.; BARTOLINI, MANUELA; ANDRISANO, VINCENZA; RECANATINI, MAURIZIO; RAMPA, ANGELA |
Autore/i Unibo: | |
Anno: | 2007 |
Rivista: | |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1021/jm070100g |
Abstract: | AP2238 was the first compound published to bind both anionic sites of the human acetylcholinesterase, allowing the simultaneous inhibition of the catalytic and the amyloid-beta pro-aggregating activities of AChE. Here we attempted to derive a comprehensive structure-activity relationship picture for this molecule, affording 28 derivatives for which AChE and BChE inhibitory activities were evaluated. Selected compounds were also tested for their ability to prevent the AChE-induced Abeta-aggregation. Moreover, docking simulations and molecular orbital calculations were performed. |
Data prodotto definitivo in UGOV: | 2007-09-29 16:23:08 |
Appare nelle tipologie: | 1.01 Articolo in rivista |
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.